series that starts with 4 is unknown.9 However, the dimethyl
homologues 8 and 9 have been prepared by Ku¨ndig and co-
workers,10 who identified the lithium amide derived from 8
as an enantioselective base with some promise,11 while more
recently the preparation of the highly oxygenated derivative
10 was described by Baudoin and co-workers.12 The
published routes to 8 and 10 both involve the late formation
of the Ar-Ar bond using Pd-catalyzed triflate-stannane
(Stille)10 or halide-boronate (Suzuki-Miyaura)12 coupling
protocols, respectively. We herein provide the details of an
alternative approach to such compounds in which the axis-
center stereochemical relay in the three-atom bridged biaryl
is exploited at the outset, using a chiral auxiliary strategy,
and in subsequent steps so as to provide (5R)-4 and (5R,7R)-8
in a concise and stereocontrolled sequence.
Scheme 1. Conformational Equilibrium in
5-Methyl-6,7-dihydro-5H-dibenz[c,e]azepine 4
ible (tropos) biaryl units in various structural roles.4 There
is a relatively low barrier to axis inversion in such units (a
value for ∆Gq of 56 kJ/mol for the inversion barrier in the
N,N-dimethylammonium bromide was estimated from NMR
data5), and the axial configuration is sensitive to central
chirality in the R-group.6 Studies into the use of homochiral
amines as reagents, catalysts, and ligands have also featured
fixed-axis dinaphthazepines such as 67 and 7.8 In contrast,
6,7-dihydro-5H-dibenz[c,e]azepines bearing substituents at
C(5) and/or C(7) are surprisingly rare, and the monoalkylated
(3) (a) Brossi, A.; Boye´, O.; Muzaffar, A.; Yeh, H. J. C.; Toome, V.;
Wegrzynski, B.; George, C. FEBS Lett. 1990, 262, 5. (b) For a pertinent
discussion, see: Cavazza, M.; Zandomeneghi, M.; Pietra, F. Tetrahedron
Lett. 2000, 41, 9129.
Our route to (5R)-4 begins with the condensation of the
biphenylcarboxylic acid 11, prepared from diphenic anhy-
dride in two steps by slight modifications of the published
procedures,13 with (R)-2-phenylglycinol 12 under the condi-
tions developed by ourselves14 and, independently, Levach-
er’s group,15 which provides the oxazolidine lactam 1315
diastereoselectively and in good yield (Scheme 2). Lactams
such as these are remarkably resistant to the formation of
acyliminiums,14b and 13 proved stable to various reduction
protocols that would normally involve such intermediates
(Et3SiH/TFA, etc.). However, lactams are susceptible to
hydroborating agents,16 and treating 13 with borane-methyl
sulfide gave a mixture of two reduction products that were
identified from spectroscopic data as the isomeric amines
15 and 16. It seemed likely that carbonyl and oxazolidine
reduction had proceeded sequentially but that the stereose-
lectivity of the second reduction step was poor. This was
remedied by reference to the pioneering work of the Meyers
group, who observed that alane often provided high diaste-
reoselectivity in this type of reduction.17 Accordingly, the
treatment of 13 with 4.7 equiv of alane gave a high yield of
one of the two amines observed previously, and this was
(4) For discussions and examples, see: (a) Mikami, K.; Aikawa, K.; Yusa,
Y.; Jodry, J. J.; Yamanaka, M. Synlett 2002, 1561. (b) Costa, A. M.; Jimeno,
C.; Gavenonis, J.; Carroll, P. J.; Walsh, P. J. J. Am. Chem. Soc. 2002, 124,
6929. (c) Ooi, T.; Uematsu, Y.; Kameda, M.; Maruoka, K. Angew. Chem.,
Int. Ed. 2002, 41, 1551. (d) Vial, L.; Lacour, J. Org. Lett. 2002, 4, 3939.
(e) Vasse, J.-L.; Stranne, R.; Zalubovskis, R.; Gayet, C.; Moberg, C. J.
Org. Chem. 2003, 68, 3258. (f) Mikami, K.; Yamanaka, M. Chem. ReV.
2003, 103, 3369. (g) Lygo, B.; Andrews, B. I. Acc. Chem. Res. 2004, 37,
518. (h) Scafato, P.; Cunsolo, G.; Labano, S.; Rosini, C. Tetrahedron 2004,
60, 8801. (i) Vachon, J.; Lauper, C.; Ditrich, K.; Lacour, J. Tetrahedron:
Asymmetry 2006, 17, 2334. (j) Aillaud, I.; Wright, K.; Collin, J.; Schulz,
E.; Mazaleyrat, J.-P. Tetrahedron: Asymmetry 2008, 19, 82.
(5) Sutherland, I. O.; Ramsay, M. V. J. Tetrahedron 1965, 21, 3401.
(6) (a) Superchi, S.; Bisaccia, R.; Casarini, D.; Laurita, A.; Rosini, C.
J. Am. Chem. Soc. 2006, 128, 6893. (b) Dutot, L.; Wright, K.; Wakselman,
M.; Mazaleyrat, J.-P.; Peggion, C.; De Zotti, M.; Formaggio, F.; Toniolo,
C. Tetrahedron Lett. 2008, 49, 3475. (c) See also: Tichy, M.; Gunterova,
J.; Zavada, J. Collect. Czech. Chem. Commun. 1997, 62, 1080.
(7) For examples and leading references, see: (a) Maigrot, N.; Maza-
leyrat, J.-P.; Welvart, Z. J. Org. Chem. 1985, 50, 3916. (b) Hawkins, J. M.;
Lewis, T. A. J. Org. Chem. 1992, 57, 2114. (c) Rosini, C.; Tanturli, R.;
Pertici, P.; Salvadori, P. Tetrahedron: Asymmetry 1996, 7, 2971. (d)
Mazaleyrat, J.-P. Tetrahedron: Asymmetry 1997, 8, 2709. (e) Widhalm, M.;
Nettekoven, U.; Mereiter, K. Tetrahedron: Asymmetry 1999, 10, 4369. (f)
Stranne, R.; Vasse, J.-L.; Moberg, C. Org. Lett. 2001, 3, 2525. (g) Ooi, T.;
Kameda, M.; Maruoka, K. J. Am. Chem. Soc. 2003, 125, 5139. (h) Ooi, T.;
Uematsu, Y.; Kameda, M.; Maruoka, K. Tetrahedron 2006, 62, 11425. (i)
Eberhardt, L.; Armspach, D.; Matt, D.; Toupet, L.; Oswald, B. Eur. J. Org.
Chem. 2007, 5395. (j) Shibatomi, K.; Tsuzuki, Y.; Nakata, S.; Sumikawa,
Y.; Iwasa, S. Synlett 2007, 551. (k) Vishnumaya; Singh, V. K. Org. Lett.
2007, 9, 1117. (l) Zalubovskis, R.; Bouet, A.; Fjellander, E.; Constant, S.;
Linder, D.; Fischer, A.; Lacour, J.; Privalov, T.; Moberg, C. J. Am. Chem.
Soc. 2008, 130, 1845. (m) Li, X.-J.; Zhang, G.-W.; Wang, L.; Hua, M.-Q.;
Ma, J.-A. Synlett 2008, 1255. (n) Mazaleyrat, J.-P.; Wright, K. Tetrahedron
Lett. 2008, 49, 4537.
(10) Saudan, L. A.; Bernardinelli, G.; Ku¨ndig, E. P. Synlett 2000, 483.
(11) Pache, S.; Botuha, C.; Franz, R.; Ku¨ndig, E. P.; Einhorn, J. HelV.
Chim. Acta 2000, 83, 2436.
(12) (a) Joncour, A.; De´cor, A.; Thoret, S.; Chiaroni, A.; Baudoin, O.
Angew. Chem., Int. Ed. 2006, 45, 4149. (b) Joncour, A.; De´cor, A.; Liu,
J.-M.; Tran Huu Dau, M.-E.; Baudoin, O. Chem. Eur. J. 2007, 13, 5450.
(13) Ried, W.; Conte, R. Chem. Ber. 1971, 104, 1573.
(8) (a) Meyers, A. I.; Nguyen, T. H. Tetrahedron Lett. 1995, 36, 5873.
(b) Rychnovsky, S. D.; McLernon, T. L.; Rajapakse, H. J. Org. Chem. 1996,
61, 1194. (c) Bourghida, M.; Widhalm, M. Tetrahedron: Asymmetry 1998,
9, 1073. (d) Pisani, L.; Superchi, S. Tetrahedron: Asymmetry 2008, 19,
1784.
(14) (a) Edwards, D. J.; Pritchard, R. G.; Wallace, T. W. Tetrahedron
Lett. 2003, 44, 4665. (b) Edwards, D. J.; House, D.; Sheldrake, H. M.;
Stone, S. J.; Wallace, T. W. Org. Biomol. Chem. 2007, 5, 2658.
(15) Penhoat, M.; Levacher, V.; Dupas, G. J. Org. Chem. 2003, 68,
9517.
(9) It is reported (Chem. Abstr. 1988, 108, 625) that the amine (()-4
was prepared, together with several homologues, in the course of a study
into the control of hyperlipidemia: Hall, I. H.; Wyrick, S. D.; Chapman,
J. M. U.S. 4689326, 1987. However, the preparative procedure and the
NMR data provided in this publication indicate that the compounds prepared
were the symmetrical N-alkyl isomers.
(16) (a) Brown, H. C.; Heim, P. J. Org. Chem. 1973, 38, 912. (b) Brown,
H. C.; Nazer, B.; Cha, J. S.; Sikorski, J. A. J. Org. Chem. 1986, 51, 5264.
(c) Collins, C. J.; Lanz, M.; Singaram, B. Tetrahedron Lett. 1999, 40, 3673.
1664
Org. Lett., Vol. 11, No. 7, 2009